Journal Article
L. E. Bermudez and Young, L. S.,
“Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.”,
Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.
L. E. Bermudez, Stevens, P., Kolonoski, P., Wu, M., and Young, L. S.,
“Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.”,
Journal of immunology (Baltimore, Md. : 1950), vol. 143, no. 9, pp. 2996-3000, 1989.
L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S.,
“Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.”,
The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S.,
“Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”,
Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.
L. E. Bermudez, Inderlied, C., and Young, L. S.,
“Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”,
Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez, Kolonoski, P., and Young, L. S.,
“Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
J. H. Champsi, Bermudez, L. E., and Young, L. S.,
“The role of cytokines in mycobacterial infection.”,
Biotherapy (Dordrecht, Netherlands), vol. 7, no. 3-4, pp. 187-93, 1994.
L. E. Bermudez, Young, L. S., and Inderlied, C. B.,
“Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.
N. Hsu, Young, L. S., and Bermudez, L. E.,
“Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex.”,
Infection and immunity, vol. 63, no. 2, pp. 528-33, 1995.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”,
The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S.,
“Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”,
Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
J. Champsi, Young, L. S., and Bermudez, L. E.,
“Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.”,
Immunology, vol. 84, no. 4, pp. 549-54, 1995.
L. S. Young, Bermudez, L. E., and Inderlied, C. B.,
“Practical issues in the antibiotic and immunotherapy of Mycobacterium avium disease in immunocompromised patients.”,
Research in microbiology, vol. 145, no. 3, pp. 206-9, 1994.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B.,
“Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”,
The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. E. Bermudez and Young, L. S.,
“Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.”,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 20, no. 2, pp. 191-201, 1987.
L. S. Young and Bermudez, L. E.,
“Perspective on animal models: chronic intracellular infections.”,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 33 Suppl 3, pp. S221-6, 2001.
L. E. Bermudez, Wu, M., Enkel, H., and Young, L. S.,
“Naturally occurring antibodies against Mycobacterium avium complex.”,
Annals of clinical and laboratory science, vol. 19, no. 6, pp. 435-43, 1989.
L. E. Bermudez, Kolonoski, P., and Young, L. S.,
“Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model.”,
Journal of leukocyte biology, vol. 47, no. 2, pp. 135-41, 1990.
N. Mohagheghpour, Gammon, D., van Vollenhoven, A., Hornig, Y., Bermudez, L. E., and Young, L. S.,
“Mycobacterium avium reduces expression of costimulatory/adhesion molecules by human monocytes.”,
Cellular immunology, vol. 176, no. 1, pp. 82-91, 1997.
N. Azouaou, Petrofsky, M., Young, L. S., and Bermudez, L. E.,
“Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.”,
Immunology, vol. 91, no. 3, pp. 414-20, 1997.
L. E. Bermudez, Inderlied, C. B., and Young, L. S.,
“Mycobacterium avium complex in AIDS.”,
Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.
OREGON STATE UNIVERSITY
Open search box
]